CRISPR/Cas9-mediated gene editing was used to introduce five point mutations into the native mouse beta-actin gene, altering it to encode gamma-actin protein. In homozygous mice, no beta-actin protein is produced, and gamma-actin is expressed under the control of the endogenous beta-actin promoter. (J:256857)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count